Guru Ownership Trend
Guru Analysis for Immunovant, Inc. (IMVT)
Immunovant, Inc. (IMVT), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 5 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $34.03 M.
Top institutional holders include Renaissance Technologies (RenTech) and David Einhorn.
Institutional sentiment is currently Bullish. This is evidenced by a $24.38 M net inflow during the quarter.
Recent activity highlights Renaissance Technologies (RenTech) who increased their stake by 277.6%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Immunovant, Inc. (IMVT)
Major holders include Renaissance Technologies (RenTech) ($28 M), David Einhorn ($3.6 M), Paul Tudor Jones ($2.2 M). According to the latest reported data, 5 tracked investment managers collectively hold approximately 918,647 shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $24.38 M, with 4 managers increasing positions and 0 managers reducing holdings.
No tracked managers reduced or fully exited their positions in IMVT during the most recent reporting period.
Yes, 3 managers opened new positions in IMVT, and 1 increased their existing holdings. The total reported buy value was $24.38 M.